4D Molecular Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Sep 2025Filed 10/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/08/2026 | Sep 2024Filed 10/11/2025 | Jun 2024Filed 10/11/2025 | Mar 2024Filed 10/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $3.8 | $3 | $0.1 | $0 | $0 | $0 | $0 | $0 | |
| −$73 | −$69 | −$57 | −$55 | −$48 | −$44 | −$35 | −$32 | |
| −$1.04 | −$1.01 | −$1.01 | −$0.98 | −$0.86 | −$0.79 | −$0.63 | −$0.66 | |
| 70 | 68 | 56 | 56 | 56 | 56 | 55 | 49 |
Trend